Agios to Present at 40th Annual J.P. Morgan Healthcare Conference on Wednesday, January 12, 2022

Rhea-AI Summary

Agios Pharmaceuticals (NASDAQ: AGIO) will present at the virtual 40th Annual J.P. Morgan Healthcare Conference on January 12, 2022, at 7:30 a.m. ET. Interested parties can access the live webcast under the "Events & Presentations" section of their website. A replay will be available for at least two weeks post-presentation. Agios focuses on developing novel medicines for genetically defined diseases, with a notable drug candidate, mitapivat, being evaluated for hemolytic anemias.

CAMBRIDGE, Mass., Dec. 22, 2021 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (NASDAQ: AGIO), a leader in the field of cellular metabolism to treat genetically defined diseases, today announced that the company is scheduled to present at the virtual 40th Annual J.P. Morgan Healthcare Conference on Wednesday, January 12, 2022, at 7:30 a.m. ET.

A live webcast of the presentation can be accessed under "Events & Presentations" in the Investors section of the company's website at www.agios.com. A replay of the webcast will be archived on the Agios website for at least two weeks following the presentation.

About Agios
Agios is focused on discovering and developing novel investigational medicines to treat genetically defined diseases through scientific leadership in the field of cellular metabolism. The company’s most advanced drug candidate is a first-in-class pyruvate kinase (PK) activator, mitapivat, that is currently being evaluated for the treatment of three distinct hemolytic anemias. In addition to its active late-stage clinical pipeline, Agios has multiple novel, investigational therapies in clinical and preclinical development. For more information, please visit the company’s website at www.agios.com.

Contacts

Investors:
Holly Manning, 617-844-6630
Senior Director, Investor Relations
Holly.Manning@agios.com

Media:
Jessica Rennekamp, 857-209-3286
Director, Corporate Communications
Jessica.Rennekamp@agios.com 

FAQ

When is Agios Pharmaceuticals presenting at the J.P. Morgan Healthcare Conference?

Agios Pharmaceuticals is scheduled to present on January 12, 2022, at 7:30 a.m. ET.

How can I access the Agios Pharmaceuticals presentation?

The presentation can be accessed via the company's website under the "Events & Presentations" section.

What is Agios Pharmaceuticals' lead drug candidate?

Agios Pharmaceuticals' most advanced drug candidate is mitapivat, a pyruvate kinase activator.

What diseases is Agios Pharmaceuticals targeting with mitapivat?

Mitapivat is being evaluated for the treatment of three distinct hemolytic anemias.

Where can I find more information about Agios Pharmaceuticals?

More information can be found on Agios Pharmaceuticals' website at www.agios.com.